BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 38757347)

  • 1. Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review).
    Zhang Y; Chu J; Hou Q; Qian S; Wang Z; Yang Q; Song W; Dong L; Shi Z; Gao Y; Meng M; Zhang M; Zhang X; Chen Q
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy.
    Jiang B; Zhang W; Zhang X; Sun Y
    Semin Cancer Biol; 2024 Jun; 101():58-73. PubMed ID: 38810814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
    Owens WA; Walaszczyk A; Spyridopoulos I; Dookun E; Richardson GD
    Mech Ageing Dev; 2021 Sep; 198():111540. PubMed ID: 34237321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application potential of senolytics in clinical treatment.
    Li T; Li S; Ma K; Kong J
    Biogerontology; 2024 Jun; 25(3):379-398. PubMed ID: 38109001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Senolytics in Cardiovascular Disease.
    Dookun E; Passos JF; Arthur HM; Richardson GD
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
    Saleh T; Carpenter VJ
    Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence in polyploid giant cancer cells: A road that leads to chemoresistance.
    Bharadwaj D; Mandal M
    Cytokine Growth Factor Rev; 2020 Apr; 52():68-75. PubMed ID: 31780423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
    Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
    Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the discovery of senolytics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions.
    Englund DA; Zhang X; Aversa Z; LeBrasseur NK
    Mech Ageing Dev; 2021 Dec; 200():111595. PubMed ID: 34742751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy.
    Sircar A; Chowdhury SM; Hart A; Bell WC; Singh S; Sehgal L; Epperla N
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.
    Carbone A; Gloghini A; Castagna L; Santoro A; Carlo-Stella C
    J Pathol; 2015 Sep; 237(1):4-13. PubMed ID: 25953622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
    Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A guide to senolytic intervention in neurodegenerative disease.
    Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
    Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.
    Maxwell SA; Mousavi-Fard S
    Exp Biol Med (Maywood); 2013 Sep; 238(9):971-90. PubMed ID: 23986223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
    Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
    EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.